322 related articles for article (PubMed ID: 19382645)
1. [Evaluation of hepatic function in new cases of pulmonary tuberculosis due to the use of standard chemotherapy regimens I and IIB].
Abdullaev RIu; Vaniev EV; Kaminskaia GO; Vasil'eva IA; Komissarova OG
Probl Tuberk Bolezn Legk; 2009; (2):57-61. PubMed ID: 19382645
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
[TBL] [Abstract][Full Text] [Related]
3. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity.
Singla R; Sharma SK; Mohan A; Makharia G; Sreenivas V; Jha B; Kumar S; Sarda P; Singh S
Indian J Med Res; 2010 Jul; 132():81-6. PubMed ID: 20693595
[TBL] [Abstract][Full Text] [Related]
5. Serum alpha-glutathione S-transferase as a sensitive marker of hepatocellular damage in patients with cystic fibrosis.
Sídlová K; Skalická V; Kotaska K; Pechová M; Chada M; Bartosová J; Hríbal Z; Nevoral J; Vávrová V; Průsa R
Physiol Res; 2003; 52(3):361-5. PubMed ID: 12790769
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum gamma-glutamyl-transferase (transpeptidase) and histological liver damage in alcoholism.
Wu A; Slavin G; Levi AJ
Am J Gastroenterol; 1976 Apr; 65(4):318-23. PubMed ID: 7137
[TBL] [Abstract][Full Text] [Related]
7. Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study.
Huang MJ; Li KL; Wei JS; Wu SS; Fan KD; Liaw YF
Am J Gastroenterol; 1994 Jul; 89(7):1071-6. PubMed ID: 7912472
[TBL] [Abstract][Full Text] [Related]
8. [Survey of anti-tuberculosis drug-induced severe liver injury in Japan].
Shigeto E;
Kekkaku; 2007 May; 82(5):467-73. PubMed ID: 17564126
[TBL] [Abstract][Full Text] [Related]
9. Transient cytokine-induced liver injury following administration of the humanized anti-CD3 antibody visilizumab (HuM291) in Crohn's disease.
Baumgart DC; Lowder JN; Targan SR; Sandborn WJ; Frankel MB
Am J Gastroenterol; 2009 Apr; 104(4):868-76. PubMed ID: 19240707
[TBL] [Abstract][Full Text] [Related]
10. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
[TBL] [Abstract][Full Text] [Related]
11. Serial changes in liver function tests in patients with thyrotoxicosis induced by Graves' disease and painless thyroiditis.
Kubota S; Amino N; Matsumoto Y; Ikeda N; Morita S; Kudo T; Ohye H; Nishihara E; Ito M; Fukata S; Miyauchi A
Thyroid; 2008 Mar; 18(3):283-7. PubMed ID: 18001177
[TBL] [Abstract][Full Text] [Related]
12. Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial.
Zhang S; Pan H; Peng X; Lu H; Fan H; Zheng X; Xu G; Wang M; Wang J
J Gastroenterol Hepatol; 2016 Feb; 31(2):409-16. PubMed ID: 26243373
[TBL] [Abstract][Full Text] [Related]
13. [Biochemical changes of liver damage factors in the course of mononucleosis like syndrome caused by cytomegalovirus].
Janeczko J
Przegl Epidemiol; 2000; 54(3-4):325-32. PubMed ID: 11349595
[TBL] [Abstract][Full Text] [Related]
14. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients.
Gomez JL; Dupont A; Cusan L; Tremblay M; Suburu R; Lemay M; Labrie F
Am J Med; 1992 May; 92(5):465-70. PubMed ID: 1349790
[TBL] [Abstract][Full Text] [Related]
15. Serum enzyme levels in alcoholism and drug dependency.
Patel S; O'Gorman P
J Clin Pathol; 1975 May; 28(5):414-7. PubMed ID: 239023
[TBL] [Abstract][Full Text] [Related]
16. [Increased liver enzymes: what should be done?].
Renner EL; Dällenbach A
Ther Umsch; 1992 May; 49(5):281-6. PubMed ID: 1352416
[TBL] [Abstract][Full Text] [Related]
17. Predictors of hepatotoxicity among patients treated with antituberculous medication.
Cusack RP; Chawke L; O'Brien DJ; O'Connor B; O'Connor TM
QJM; 2017 Apr; 110(4):219-225. PubMed ID: 27667826
[TBL] [Abstract][Full Text] [Related]
18. Assessment of prescribed herbal medicine on liver function in Korea: a prospective observational study.
Yun YJ; Nah SS; Park JH; Jung SK; Paeck EK; Park JH; Lee EJ; Kim SH; Park HM; Lee SD; Kim JY; Hong SJ; Choe BK; Chung JH
J Altern Complement Med; 2008 Nov; 14(9):1131-6. PubMed ID: 18991516
[TBL] [Abstract][Full Text] [Related]
19. Liver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures.
Froud T; Venkat SR; Barbery KJ; Gunjan A; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):140-6. PubMed ID: 26365543
[TBL] [Abstract][Full Text] [Related]
20. Serum hepatic biochemical activity in two populations of workers exposed to styrene.
Brodkin CA; Moon JD; Camp J; Echeverria D; Redlich CA; Willson RA; Checkoway H
Occup Environ Med; 2001 Feb; 58(2):95-102. PubMed ID: 11160987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
